Search results
Results From The WOW.Com Content Network
India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a year amid an expanding ...
Covaxin (development name, BBV152) is a whole inactivated virus -based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research - National Institute of Virology. [2]
Bharat Biotech International Limited (BBIL) is an Indian multinational biotechnology company based in Hyderabad, which is engaged in drug discovery, drug development, and the manufacture of vaccines, biotherapeutics, pharmaceuticals and healthcare products.
iNCOVACC. Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom. iNCOVACC (codenamed BBV154) [ 1 ] is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, [ 2 ][ 3 ] American company Precision Virologics [ 4 ][ 5 ] and the Washington University School of Medicine in St Louis ...
Dr. Krishna Ella is an Indian scientist and entrepreneur. He is the founder and Executive Chairman of Bharat Biotech. [1][2] Ella and his company were responsible for developing India's own COVID-19 vaccine, Covaxin, World's 1st clinically proven conjugated Typhoid Vaccine, TypbarTCV and ROTAVAC. [3][4] Ella worked as a research faculty at the ...
‹ The template Infobox event is being considered for merging. › COVID-19 vaccination programme Per capita fully vaccination map as of 4 April 2023 Date 16 January 2021 (2021-01-16) – present (3 years, 258 days ago) Location India Cause COVID-19 pandemic in India Target Immunisation of Indians against COVID-19 Budget ₹ 35,000 crore (US$4.2 billion) Organised by Government of India ...
Bharat Biotech COVID-19 vaccine may refer to one or both of the following: Covaxin , a whole-inactivated-virus-based vaccine delivered by injection iNCOVACC , an adenovirus vectored intranasal COVID-19 vaccine
Biotechnology in India. Biotechnology in India is a sunrise sector within the Indian economy. [1] Agencies of the Government of India concerned with the biotechnology industry include the Department of Biotechnology and the proposed Biotechnology Regulatory Authority of India. As of 2022, the sector is valued at $80 billion. [2]